A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer (DTC)
- First Posted Date
- 2011-03-23
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 392
- Registration Number
- NCT01321554
- Locations
- 🇬🇧
Facility 2, Manchester, United Kingdom
🇬🇧Facility 3, London, United Kingdom
🇬🇧Facility 1, Sutton, United Kingdom
A Study to Assess the Transfer of Fospropofol and Its Active Metabolite, Propofol, to Breast Milk Following Administration of LUSEDRA to Lactating Women Undergoing a Needed Procedure
- First Posted Date
- 2011-03-07
- Last Posted Date
- 2015-11-03
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT01309984
- Locations
- 🇺🇸
NorthShore University HealthSystem, Evanston, Illinois, United States
A Study to Characterize Pharmacokinetics (PK) and Pharmacodynamics (PD) of LUSEDRA® Administered as Continuous Infusion or Bolus Compared With Continuous Infusion of Propofol Injectable Emulsion
Phase 1
Completed
- Conditions
- Monitored Anesthesia Care
- Interventions
- First Posted Date
- 2011-03-04
- Last Posted Date
- 2015-11-03
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT01308541
- Locations
- 🇺🇸
University of Utah, Salt Lake City Utah, Utah, United States
Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2609 in Healthy Subjects and an Elderly Cohort
Phase 1
Completed
- Conditions
- Alzheimer's Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2011-02-11
- Last Posted Date
- 2013-08-29
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 73
- Registration Number
- NCT01294540
- Locations
- 🇺🇸
Glendale Adventist Medical Center, Glendale, California, United States
A Study to Evaluate the Relative Bioavailability and Intra-Subject Variability of Two Lots of E5501 40 mg Tablets Administered Twice as Single Oral Doses to Healthy Subjects
- First Posted Date
- 2011-02-03
- Last Posted Date
- 2013-11-01
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 42
- Registration Number
- NCT01289509
- Locations
- 🇺🇸
PRA, Lenexa, Kansas, United States
A Study to Investigate Use Patterns and Safety in Simulated Actual Over-the-counter (OTC) Use of Rabeprazole Sodium for the Treatment of Heartburn Symptoms
- First Posted Date
- 2011-01-31
- Last Posted Date
- 2011-01-31
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 1500
- Registration Number
- NCT01286194
- Locations
- 🇺🇸
Eckerd Drug #234, Marietta, Georgia, United States
🇺🇸The Medicine Shoppe, Kansas Ciry, Kansas, United States
🇺🇸Studewood Pharmacy, Houston, Texas, United States
A Study to Evaluate the Safety and Efficacy of Zonisamide an Antiepileptic Drug as Monotherapy or Adjunctive Therapy in Treatment of Adult Patients With Partial, Generalized or Combined Seizures.
- First Posted Date
- 2011-01-25
- Last Posted Date
- 2014-01-27
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 655
- Registration Number
- NCT01283256
A Study Versus E2020 10mg Followed by an Open-label Extension Phase to Explore the Safety of E2020 SR 23 mg in Japanese Subjects With Severe Alzheimer's Type Dementia
- First Posted Date
- 2011-01-13
- Last Posted Date
- 2014-08-08
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 45
- Registration Number
- NCT01276353
E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Participants With Hepatocellular Carcinoma
- First Posted Date
- 2011-01-06
- Last Posted Date
- 2021-05-12
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 102
- Registration Number
- NCT01271504
Eribulin With Trastuzumab as First-line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer
- First Posted Date
- 2011-01-04
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 52
- Registration Number
- NCT01269346
- Locations
- 🇺🇸
Heartland Regional Medical Center, Saint Joseph, Missouri, United States
🇺🇸Texas Oncology - Medical City Dallas, Dallas, Texas, United States
🇺🇸Peachtree Hematology Oncology Associates, PC, Atlanta, Georgia, United States
© Copyright 2025. All Rights Reserved by MedPath